Trial intelligence / Profile preview

Safety and PK/PD of HSK3486 vs Propofol in Healthy Subjects

NCT03745625Phase 1Completed

Sponsor
Sichuan Haisco Pharmaceutical Co., Ltd.
Start
Jan 2019
Primary completion
Jul 2019
Modality
Allosteric Modulators
Countries
1
01

Overview

Phase 1, randomised, open-label trial of ciprofol in Anesthesia and sedation (2 arms), sponsored by Sichuan Haisco Pharmaceutical Co., Ltd. Primary endpoints: blood pressure (systolic, diastolic and mean arterial pressure), heart rate and 3 more. Started Jan 2019; status: completed.

02

Drugs

ciprofol
03

Conditions

Anesthesiasedation

Beyond the preview

Go deeper on NCT03745625.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03745625.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call